Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III Trial

INTRODUCTION: Poor prognosis patients with bulky stage III locally advanced non–small-cell lung cancer may not be offered concurrent chemoradiotherapy (CRT). Following a phase III trial concerning the effect of palliative CRT in inoperable poor prognosis patients, this analysis was performed to expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Strøm, Hans H., Bremnes, Roy M., Sundstrøm, Stein H., Helbekkmo, Nina, Aasebø, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132042/
https://www.ncbi.nlm.nih.gov/pubmed/24807158
http://dx.doi.org/10.1097/JTO.0000000000000184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132042/
https://www.ncbi.nlm.nih.gov/pubmed/24807158
http://dx.doi.org/10.1097/JTO.0000000000000184

Ejemplares similares